Clinical Trials Directory

Trials / Unknown

UnknownNCT04726683

Dry Needling vs Injection in Patients With Temporomandibular Disorders

Trigger Point Dry Needling vs Injection in Patients With Temporomandibular Disorders: a Randomized Placebo-controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
Josue Fernandez Carnero · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The main objective is to compare the effectiveness of dry needling in improving pain and disability versus placebo, and versus infiltration, in patients with myofascial temporomandibular dysfunction in the short, medium and long term.

Conditions

Interventions

TypeNameDescription
PROCEDUREDry needling and placebo injectionDry Needling is applied with a filiform needle to penetrate the skin and stimulate the underlying myofascial trigger point of the masseter muscle. Dry needling is combined with placebo injection, in which the tip of a beveled needle is cut and the process of injection is simulated without penetrating the skin.
PROCEDUREInjection and placebo dry needlingLidocaine injection applied in the myofascial trigger point of the masseter muscle. Lidocaine injection is combined with placebo dry needling, in which the tip of a filiform needle is cut and the dry needling technique simulated without penetrating the skin
PROCEDUREDry needling and injectionDry Needling is applied with a filiform needle to penetrate the skin and stimulate the underlying myofascial trigger point of the masseter muscle. Dry needling is combined with lidocaine injection applied in the myofascial trigger point of the masseter muscle.
PROCEDUREPlacebo dry needling and placebo injectionPlacebo dry needling, in which the tip of a filiform needle is cut and the dry needling technique simulated without penetrating the skin. Placebo dry needling is combined with placebo injection, in which the tip of a beveled needle is cut and the process of injection is simulated without penetrating the skin

Timeline

Start date
2020-11-23
Primary completion
2023-12-15
Completion
2024-12-15
First posted
2021-01-27
Last updated
2023-11-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04726683. Inclusion in this directory is not an endorsement.